Progression of Glomerular Sclerosis in Experimental Uremic Rats by Administration of Indole, a Precursor of Indoxyl Sulfate
The DOI matches its Crossref record.
Abstract
In uremia there is a marked elevation of serum levels of indoxyl sulfate due to its decreased renal clearance. Indoxyl sulfate is synthesized in the liver from indole which is produced by bacteria in the intestines. To determine the role of indoxyl sulfate in the progression of chronic renal failure, we administered indole, the precursor of indoxyl sulfate, to subtotally nephrectomized uremic rats. The oral administration of indole increased the serum levels of creatinine and blood urea nitrogen and decreased creatinine, inulin, and p-aminohippuric acid clearances. The glomerular sclerosis index in the indole-treated rats was higher than in the control uremic rats. After oral administration, indole could not be detected in the urine, but large amounts of its metabolite, indoxyl sulfate. Thus, indole administration stimulated glomerular sclerosis in a uremic model through the production of indoxyl sulfate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Yesbolatova, A., Saito, Y., Kitamoto, N., Makino-Itou, H., Ajima, R., Nakano, R., Nakaoka, H., Fukui, K., Gamo, K., Tominari, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19532-z · Cited by 533
Lo, K. K.-W., Choi, A. W.-T., & Law, W. H.-T. (2012) · Dalton Transactions · doi:10.1039/c2dt11892k · Cited by 386
Enomoto, A., Takeda, M., Tojo, A., Sekine, T., Cha, S. H., Khamdang, S., Takayama, F., Aoyama, I., Nakamura, S., Endou, H., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000022017.96399.b2 · Cited by 301
Self-citationModulation of a Circulating Uremic Solute via Rational Genetic Manipulation of the Gut Microbiota
Devlin, A. S., Marcobal, A., Dodd, D., Nayfach, S., Plummer, N., Meyer, T., Pollard, K. S., Sonnenburg, J. L., & Fischbach, M. A. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.10.021 · Cited by 301
Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease
Kikuchi, K., Saigusa, D., Kanemitsu, Y., Matsumoto, Y., Thanai, P., Suzuki, N., Mise, K., Yamaguchi, H., Nakamura, T., Asaji, K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09735-4 · Cited by 298
Effects of renal failure on drug transport and metabolism
Sun, H., Frassetto, L., & Benet, L. Z. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.05.010 · Cited by 290
Itoh, Y., Ezawa, A., Kikuchi, K., Tsuruta, Y., & Niwa, T. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-5929-3 · Cited by 288
Self-citationMotojima, M., Hosokawa, A., Yamato, H., Muraki, T., & Yoshioka, T. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00906.x · Cited by 278
Indoxyl Sulfate—Review of Toxicity and Therapeutic Strategies
Leong, S., & Sirich, T. (2016) · Toxins · doi:10.3390/toxins8120358 · Cited by 272
Organic anion transporter (Slc22a) family members as mediators of toxicity
Sweet, D. H. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.10.016 · Cited by 150
The microbiota and chronic kidney diseases: a double‐edged sword
Felizardo, R. J. F., Castoldi, A., Andrade‐Oliveira, V., & Câmara, N. O. S. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.36 · Cited by 85
Ito, S., Higuchi, Y., Yagi, Y., Nishijima, F., Yamato, H., Ishii, H., Osaka, M., & Yoshida, M. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0112023 · Cited by 72
Metadata
- Authors
- Niwa, T., Ise, M., & Miyazaki, T.
- Venue
- American Journal of Nephrology
- Publisher
- S. Karger AG
- Published
- 1994
- Volume
- 14
- Issue
- 3
- Pages
- 207-212
- ISSN
- 0250-8095 (ISSN-L)
- 1421-9670
- OpenAlex
- W2065672265
- Cited by
- 178
- References
- 0
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.